Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!
Siirry offline-tilaan Player FM avulla!
Anticholinergic drugs and dementia: a causal link?
MP3•Jakson koti
Manage episode 343120516 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Anticholinergic drug use is on the rise due to the COVID-19 pandemic and the UK medicines regulator is also considering extending access to the anticholinergic bladder drug oxybutynin over the counter. In this episode, we will look at the potential implications of these changes, particularly in older people, and examine the case for deprescribing. We will also assess emerging evidence that suggests that the cumulative burden of anticholinergics over a lifetime could be a causal factor for dementia. Thank you to Graham Stretch, chief pharmacist at the Argyle Group in west London, his patient Miriam* who agreed for us to record her consultation, and also to Chris Fox, professor of clinical psychiatry at the University of East Anglia. This programme is presented by executive editor Nigel Praities and senior data journalist Julia Robinson. It was produced by Geoff Marsh. *Some details have been changed to ensure confidentiality.
…
continue reading
43 jaksoa
MP3•Jakson koti
Manage episode 343120516 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Anticholinergic drug use is on the rise due to the COVID-19 pandemic and the UK medicines regulator is also considering extending access to the anticholinergic bladder drug oxybutynin over the counter. In this episode, we will look at the potential implications of these changes, particularly in older people, and examine the case for deprescribing. We will also assess emerging evidence that suggests that the cumulative burden of anticholinergics over a lifetime could be a causal factor for dementia. Thank you to Graham Stretch, chief pharmacist at the Argyle Group in west London, his patient Miriam* who agreed for us to record her consultation, and also to Chris Fox, professor of clinical psychiatry at the University of East Anglia. This programme is presented by executive editor Nigel Praities and senior data journalist Julia Robinson. It was produced by Geoff Marsh. *Some details have been changed to ensure confidentiality.
…
continue reading
43 jaksoa
Alla avsnitt
×Tervetuloa Player FM:n!
Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.